CN101124340A - 血液淋巴细胞中子宫内膜异位症的分子诊断标志物的鉴定 - Google Patents

血液淋巴细胞中子宫内膜异位症的分子诊断标志物的鉴定 Download PDF

Info

Publication number
CN101124340A
CN101124340A CNA2005800484494A CN200580048449A CN101124340A CN 101124340 A CN101124340 A CN 101124340A CN A2005800484494 A CNA2005800484494 A CN A2005800484494A CN 200580048449 A CN200580048449 A CN 200580048449A CN 101124340 A CN101124340 A CN 101124340A
Authority
CN
China
Prior art keywords
value
endometriosis
gene expression
gene
peripheral blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800484494A
Other languages
English (en)
Chinese (zh)
Inventor
伊达哈里兹·弗洛里斯
斯皮罗·莫萨斯
埃斯特尔·罗森布卢姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goverment Of United States, AS REPRESENTED BY SECRETARY D
Original Assignee
Goverment Of United States, AS REPRESENTED BY SECRETARY D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goverment Of United States, AS REPRESENTED BY SECRETARY D filed Critical Goverment Of United States, AS REPRESENTED BY SECRETARY D
Publication of CN101124340A publication Critical patent/CN101124340A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2005800484494A 2005-02-18 2005-12-09 血液淋巴细胞中子宫内膜异位症的分子诊断标志物的鉴定 Pending CN101124340A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65433105P 2005-02-18 2005-02-18
US60/654,331 2005-02-18

Publications (1)

Publication Number Publication Date
CN101124340A true CN101124340A (zh) 2008-02-13

Family

ID=36182367

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800484494A Pending CN101124340A (zh) 2005-02-18 2005-12-09 血液淋巴细胞中子宫内膜异位症的分子诊断标志物的鉴定

Country Status (13)

Country Link
US (1) US20090208939A1 (enExample)
EP (1) EP1848818A1 (enExample)
JP (1) JP2008537474A (enExample)
KR (1) KR20080016789A (enExample)
CN (1) CN101124340A (enExample)
AU (1) AU2005327929A1 (enExample)
BR (1) BRPI0520012A2 (enExample)
CA (1) CA2596932A1 (enExample)
IL (1) IL184920A0 (enExample)
MX (1) MX2007009562A (enExample)
NO (1) NO20074762L (enExample)
WO (1) WO2006091254A1 (enExample)
ZA (1) ZA200707752B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107326065A (zh) * 2016-04-29 2017-11-07 博尔诚（北京）科技有限公司 一种基因标识物的筛选方法及其应用
WO2018049946A1 (zh) * 2016-09-19 2018-03-22 深圳华大基因研究院 用于子宫腺肌症检测的生物标志物组合及其应用
CN108456723A (zh) * 2018-03-21 2018-08-28 福州福瑞医学检验实验室有限公司 一种子宫内膜异位症风险预测的基因检测引物和试剂盒
CN112470002A (zh) * 2018-04-20 2021-03-09 德克萨斯大学体系董事会 用于治疗子宫内膜异位症的组合物和方法

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9222938B2 (en) * 2001-12-04 2015-12-29 Michael Tainsky Neoepitope detection of disease using protein arrays
EP2118321A4 (en) * 2007-02-06 2010-06-30 Genizon Biosciences GENCARTS OF HUMAN GENES ASSOCIATED WITH ENDOMETRIOSIS
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
WO2009140126A1 (en) * 2008-05-14 2009-11-19 Juneau Biosciences, Llc Method of administering a therapeutic
JP5503942B2 (ja) * 2009-10-30 2014-05-28 シスメックス株式会社 疾患の罹患の判定方法
EP2348129A1 (en) * 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
KR101333207B1 (ko) * 2011-07-13 2013-11-26 부산대학교 산학협력단 자궁내막증과 연관된 유전자 마커 및 이의 용도
DK2773779T3 (da) 2011-11-04 2020-11-23 Population Bio Inc Fremgangsmåder og sammensætninger til diagnosticering, prognose og forebyggelse af neurologiske tilstande
EP2812452B1 (en) 2012-02-09 2020-05-27 Population Bio, Inc. Methods and compositions for screening and treating developmental disorders
KR101445560B1 (ko) 2012-05-10 2014-09-29 한국수력원자력 주식회사 저준위 전리방사선에 민감한 유전자 검출 방법 및 상기 방법으로 검출된 유전자
US9976180B2 (en) 2012-09-14 2018-05-22 Population Bio, Inc. Methods for detecting a genetic variation in subjects with parkinsonism
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
WO2014209238A1 (en) * 2013-06-28 2014-12-31 Acumen Research Laboratories Pte. Ltd. Sepsis biomarkers and uses thereof
EP3511422B1 (en) * 2013-11-12 2022-12-28 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating endometriosis
DE102014203235A1 (de) * 2014-02-24 2015-08-27 Mahle International Gmbh Klimagerät, insbesondere für ein Kraftfahrzeug und Verfahren zur Herstellung einer Komponente eines Klimagerätes
RU2558854C1 (ru) * 2014-06-23 2015-08-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Способ прогнозирования риска развития эндометриоза
JP2016077234A (ja) * 2014-10-17 2016-05-16 国立大学法人鳥取大学 子宮内膜症の早期診断のための診断キット、診断マーカー及び検出方法
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
WO2019169113A1 (en) * 2018-03-02 2019-09-06 Ponce Medical School Foundation, Inc. Compositions and methods for the treatment of endometriosis
US11906529B1 (en) * 2018-04-27 2024-02-20 Marshall University Research Corporation Methods for treatment and diagnosis of endometriosis
WO2020033700A1 (en) 2018-08-08 2020-02-13 Pml Screening, Llc Mathods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing
WO2024263816A2 (en) * 2023-06-21 2024-12-26 Cristcot Llc Development and validation of the hemorrhoid disease symptom impact measure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003253440A1 (en) * 2002-08-30 2004-04-30 Japan As Represented By The President Of The University Of Tokyo Method of diagnosing ovarian endometriosis

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107326065A (zh) * 2016-04-29 2017-11-07 博尔诚（北京）科技有限公司 一种基因标识物的筛选方法及其应用
CN107326065B (zh) * 2016-04-29 2022-07-29 博尔诚（北京）科技有限公司 一种基因标识物的筛选方法及其应用
WO2018049946A1 (zh) * 2016-09-19 2018-03-22 深圳华大基因研究院 用于子宫腺肌症检测的生物标志物组合及其应用
CN109689890A (zh) * 2016-09-19 2019-04-26 深圳华大生命科学研究院 用于子宫腺肌症检测的生物标志物组合及其应用
CN108456723A (zh) * 2018-03-21 2018-08-28 福州福瑞医学检验实验室有限公司 一种子宫内膜异位症风险预测的基因检测引物和试剂盒
CN112470002A (zh) * 2018-04-20 2021-03-09 德克萨斯大学体系董事会 用于治疗子宫内膜异位症的组合物和方法

Also Published As

Publication number Publication date
EP1848818A1 (en) 2007-10-31
MX2007009562A (es) 2008-03-11
NO20074762L (no) 2007-11-16
CA2596932A1 (en) 2006-08-31
WO2006091254A1 (en) 2006-08-31
ZA200707752B (en) 2010-05-26
AU2005327929A1 (en) 2006-08-31
JP2008537474A (ja) 2008-09-18
KR20080016789A (ko) 2008-02-22
IL184920A0 (en) 2007-12-03
US20090208939A1 (en) 2009-08-20
BRPI0520012A2 (pt) 2009-04-14

Similar Documents

Publication Publication Date Title
CN101124340A (zh) 血液淋巴细胞中子宫内膜异位症的分子诊断标志物的鉴定
US9746479B2 (en) Methods and compositions to predict and detect acute rejection
US20160168649A1 (en) Gene expression predictors of cancer prognosis
US20110166028A1 (en) Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancers
US20180148794A1 (en) Methods of prostate cancer prognosis
CN102443627A (zh) 用于乳腺癌的预后的方法和试剂盒
US20110143946A1 (en) Method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent
US10604809B2 (en) Methods and kits for the diagnosis and treatment of pancreatic cancer
US8257917B2 (en) Salivary biomarkers for Sjögren's syndrome
WO2007100913A2 (en) Genes differentially expressed in bipolar disorder and/or schizophrenia
KR101346955B1 (ko) 뇌종양의 재발 가능성 및 생존 예후 예측용 조성물 및 이를 포함하는 키트
US20130217656A1 (en) Methods and compositions for diagnosing and treating lupus
US10066270B2 (en) Methods and kits used in classifying adrenocortical carcinoma
US20120289416A1 (en) Methods and kits used in assessing cancer risk
WO2014173986A2 (en) Methods for diagnosing and monitoring the response to treatment of hepatocellular carcinoma
KR101540052B1 (ko) 난소암 환자의 항암제 치료 반응성 예측을 위한 마커 kdm4d
KR20170095761A (ko) TMEM57 또는 NudC 유전자를 이용한 백혈병 진단용 조성물
HK1213297A1 (zh) 用於检测和测定前列腺癌预後的组合物和方法
HK1213297B (zh) 用於檢測和測定前列腺癌預後的組合物和方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080213